Table 3.

Cumulative Sputum Culture Conversion by Selected Characteristics (N = 119)

Covariate	Cumulative Culture Conversion				P Value
	12 wks		24 wks
	n/N	%	n/N	%
OVERALL	30/119	25	87/119	73	…
Group
Pre-test implementation	5/68	7	43/68	63	<.01
Post-test implementation	25/51	49	44/51	86
Gender
Male	17/82	21	58/82	71	.20
Female	13/37	35	29/37	78
BMI (kg/m2)
≤18.5	10/31	32	20/31	65	.60
>18.5	20/88	23	67/88	76
Tuberculosis history
Yes	12/48	25	31/48	65	.18
No	18/71	25	56/71	79
Diabetes mellitus
Yes	3/15	20	12/15	80	.74
No	27/104	26	75/104	72
Hepatitis C
Yes	2/9	22	4/9	44	.16
No	28/110	26	83/110	76
Cavitary disease
Yes	3/21	14	12/21	57	.11
No	27/98	28	75/98	77
XDR
Yes	0/7	0	5/7	71	.63
No	30/112	27	82/112	73
Ofloxacin resistance
Yes	0/13	0	6/13	46	.03
No	30/106	28	81/106	76
Capreomycin or kanamycin resistance
Yes	14/42	33	32/42	76	.36
No	16/77	21	55/77	71
Initial treatment with kanamycin
Yes	20/68	29	52/68	77	.11
No	10/51	20	35/51	69
Treatment interruption
Yes	13/46	28	34/46	74	.72
No	17/73	23	53/73	73

Abbreviations: BMI, body mass index; XDR, extensively drug-resistant.